Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events
1820796 / Pixabay

Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events

According to a story from Cancer Therapy Advisor, a recent study published in the journal Cancer Medicine indicated that chronic lymphocytic leukemia (CLL) patients who dealt with adverse events during treatment…

Continue Reading Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events

Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate

According to a press release from the French biotechnology company Inventiva, the company has completed recruitment for a phase 2 clinical trial evaluating its experimental mucopolysaccharidosis VI drug, odiparcil. About…

Continue Reading Patient Recruitment Completed for Phase 2 Study of Mucopolysaccharidosis VI Drug Candidate
Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
crystal710 / Pixabay

Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference

Von Willebrand disease is the most common inherited blood clotting disorder that affects humans. The disorder can also be acquired. Although it is considered common, the majority of cases do…

Continue Reading Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
Belova59 / Pixabay

Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease

According to a story from Charcot-Marie-Tooth News, a recent study was conducted that compared the presentation of symptoms between two different variants of Charcot-Marie-Tooth disease (CMT): CMT4B1 and CMT4B2. The…

Continue Reading Study Identifies Differences in Progression and Onset Between Type 4B1 and 4B2 Charcot-Marie-Tooth Disease
A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body
source: pixabay.com

A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body

  The blood-brain barrier is a “gatekeeper” that prevents toxins and foreign matter in the bloodstream from traveling to the brain. Check Orphan recently carried an article that had been…

Continue Reading A New Way to Study Disease: Scientists Have Recreated a Blood-Brain Barrier Outside the Body